Philips Korea CEO Choi Nak-hoon / Courtesy of Philips Korea
As governments and industry leaders race to establish guardrails for artificial intelligence (AI) in health care, Philips Korea CEO Choi Nak-hoon has been recognized for helping connect global regulatory discussions with Korea’s rapidly evolving medical device sector.
Choi received a commendation from the commissioner of the Ministry of Food and Drug Safety during the 19th Medical Devices Day ceremony, Philips Korea said Sunday. Choi was recognized for his contributions to the development of the medical device industry and the advancement of public health.
The company said Choi played a key role in expanding international regulatory cooperation in the field of AI-powered medical devices through AIRIS 2025, an international symposium on AI medical product regulation jointly organized by the ministry and the World Health Organization in 2025.
According to Philips Korea, Choi oversaw participation by both Philips headquarters and its Korean operations in the event, helping facilitate exchanges between global and domestic stakeholders on emerging regulatory frameworks for AI in health care.
